Skip to main content
SpringerLink
Log in

Uterine Cancer Surgery

  • Chapter
  • First Online:
Anesthesia for Oncological Surgery

  • 141 Accesses

Abstract

Surgery, if feasible, is the definitive primary treatment for most patients. Chemotherapy, hormone therapy or radiation therapy are alternative treatment options for inoperable patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AKI:

Acute kidney injury

CHF:

Congestive heart failure

EC:

Endometrial cancer

GBS:

Guillain-Barré syndrome

HNPCC:

Hereditary non-polyposis colon cancer

HRT:

Hormone replacement therapy

HTN:

Hypertension

IUDs:

Intrauterine devices

LV:

Left ventricle

MG:

Myasthenia gravis

MIS:

Minimally invasive surgery

OR:

Odds ratio

OSA:

Obstructive Sleep Apnea

PCOS:

Polycystic ovarian syndrome

PONV:

Postoperative nausea and vomiting

RR:

Relative risk

SDD:

Same day discharge

TIVA:

Total intravenous anesthesia

TP:

Trendelenburg position

VTE:

Venous thromboembolism

References

  1. https://seer.cancer.gov/statfacts/html/corp.html

  2. https://www.cdc.gov/mmwr/volumes/67/wr/mm6748a1.htm

  3. Gong TT, Wang YL, Ma XX. Age at menarche and endometrial cancer risk: a dose-response meta-analysis of prospective studies. Sci Rep. 2015;5:14051.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman D, Greenlee RT, Linet MS, et al. An aggregated analysis of hormonal factors and endometrial cancer risk by parity. Cancer. 2013;119(7):1393–401.

    Article  PubMed  Google Scholar 

  5. Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, et al. Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. Am J Epidemiol. 2012;176(4):269–78.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wu Y, Sun W, Liu H, Zhang D. Age at menopause and risk of developing endometrial cancer: a meta-analysis. Biomed Res Int. 2019;2019:8584130.

    PubMed  PubMed Central  Google Scholar 

  7. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.

    Article  PubMed  Google Scholar 

  8. Crosbie E, Zwahlen M, Kitchener H, Egger M, Renehan A. Body mass index, hormone replacement therapy and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2010;19(12):3119–30. https://doi.org/10.1158/1055-9965.EPI-10-0832.

    Article  CAS  Google Scholar 

  9. Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(5):748–58.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Starup-Linde J, Karlstad O, Eriksen SA, Vestergaard P, Bronsveld HK, de Vries F, et al. CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants—a systematic review and a meta-analysis. Curr Drug Saf. 2013;8(5):296–332.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Zhang ZH, Su PY, Hao JH, Sun YH. The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies. Int J Gynecol Cancer. 2013;23(2):294–303.

    Article  PubMed  Google Scholar 

  12. Aune D, Sen A, Vatten LJ. Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies. Sci Rep. 2017;7:–44808.

    Google Scholar 

  13. Kitson SJ, Lindsay J, Sivalingam VN, Lunt M, Ryan NAJ, Edmondson RJ, et al. The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: a prospective case control study. Gynecol Oncol. 2018;148(1):154–60.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol. 1995;85(2):304–13.

    Article  CAS  PubMed  Google Scholar 

  15. Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the million women study. Lancet. 2005;365(9470):1543–51.

    Article  PubMed  Google Scholar 

  16. Sismondi P, Biglia N, Volpi E, Giai M, deGrandis T. Tamoxifen and endometrial cancer. Ann N Y Acad Sci. 1994;734:310–21.

    Article  CAS  PubMed  Google Scholar 

  17. Bissett D, Davis JA, George WD. Gynaecological monitoring during tamoxifen therapy. Lancet. 1994;344:1244.

    Article  CAS  PubMed  Google Scholar 

  18. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst. 1994;86:527–37.

    Article  CAS  PubMed  Google Scholar 

  19. Vasen HFA, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut. 2013;62:812–23.

    Article  CAS  PubMed  Google Scholar 

  20. Janda M, Robledo K, Gebski V, et al. Complete pathological response following levonorgestrel intrauterine in clinical stage 1 endometrial adenocarcinoma: Results of a clinical trial (feMMe trial, ANZGOG 1301). Gynecologic Oncology. 2021;161(1):143–51, ISSN 0090-8258, https://doi.org/10.1016/j.ygyno.2021.01.029.

  21. Felix AS, Gaudet MM, La Vecchia C, et al. Intrauterine devices and endometrial cancer risk: a pooled analysis of the epidemiology of endometrial cancer consortium. Int J Cancer. 2015;136:E410–22.

    Article  CAS  PubMed  Google Scholar 

  22. Collaborative Group on Epidemiological Studies on endometrial cancer endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27,276 women with endometrial cancer from 36 epidemiological studies. Lancet Oncol. 2015;16:1061–1070.

    Google Scholar 

  23. Upala S, Sanguankeo A. Bariatric surgery reduces risk of endometrial cancer. Surg Obes Relat Dis. 2015;11:1410.

    Article  PubMed  Google Scholar 

  24. Null DB, Weiland CM, Camlibel AR. Postmenopausal bleeding—first steps in the workup. J Fam Pract. 2012;61:597–604.

    PubMed  Google Scholar 

  25. Clarke MA, Long BJ, Sherman ME, Lemens MA, Podratz KC, Hopkins MR, Ahlberg LJ, Mc Guire LJ, Laughlin-Tommaso SK, Bakkum-Gamez JN, Wentzensen N. Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms. Am J Obstet Gynecol. 2020;223(4):549.e1–549.e13. https://doi.org/10.1016/j.ajog.2020.03.032. Epub 2020 Apr 5. PMID: 32268124; PMCID: PMC7529796.

    Article  PubMed  Google Scholar 

  26. Havrilesky LJ, Cragun JM, Calingaert B, et al. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Gynecol Oncol. 2007;104:401–5.

    Article  PubMed  Google Scholar 

  27. Slomovitz BM, Ramondetta LM, Lee CM, et al. Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int J Gynecol Cancer. 2005;15:510–6.

    Article  CAS  PubMed  Google Scholar 

  28. Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, Barakat R, Pearl ML, Sharma SK. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 study. J Clin Oncol. 2012;30(7):695–700. https://doi.org/10.1200/JCO.2011.38.8645. Epub 2012 Jan 30. Erratum in: J Clin Oncol. 2012 May 1;30(13):1570. PMID: 22291074; PMCID: PMC3295548.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Janda M, Gebski V, Davies LC, et al. Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer: a randomized clinical trial. JAMA. 2017;317(12):1224–33. https://doi.org/10.1001/jama.2017.2068.

    Article  PubMed  Google Scholar 

  30. Ackerman RS, Muncey AR, Aldawoodi NN, Kotha R, Getting REG. Cancer immunotherapies: what the perioperative physician needs to know. Curr Oncol Rep. 2022;24(4):399–414.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Gelineau AM, King MR, Ladha KS, Burns SM, Houle T, Anderson TA. Intraoperative Esmolol as an adjunct for perioperative opioid and postoperative pain reduction: a systematic review, meta-analysis, and meta-regression. Anesth Analg. 2018;126(3):1035–49.

    Article  CAS  PubMed  Google Scholar 

  32. Aceto P, Beretta L, Cariello C, Claroni C, Esposito C, Forastiere EM, Guarracino F, Perucca R, Romagnoli S, Sollazzi L, et al. Joint consensus on anesthesia in urologic and gynecologic robotic surgery: specific issues in management from a task force of the SIAARTI, SIGO, and SIU. Minerva Anestesiol. 2019;85(8):871–85.

    Article  PubMed  Google Scholar 

  33. Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, Taylor JS, Iniesta M, Lasala J, Mena G, et al. Guidelines for perioperative care in gynecologic/oncology: enhanced recovery after surgery (ERAS) society recommendations-2019 update. Int J Gynecol Cancer. 2019;29(4):651–68.

    Article  PubMed  Google Scholar 

  34. Ali SME, Hafeez MH, Nisar O, Fatima S, Ghous H, Rehman M. Role of preoperative erythropoietin in the optimization of preoperative anemia among surgical patients—a systematic review and meta-analysis. Hematol Transfus Cell Ther. 2022;44(1):76–84.

    Article  PubMed  Google Scholar 

  35. Stout NL, Wagner SS. Antineoplastic therapy side effects and polypharmacy in older adults with cancer. Top Geriatr Rehabil. 2019;35(1):15–30.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Nahas S, Feigenberg T, Park S. Feasibility and safety of same-day discharge after minimally invasive hysterectomy in gynecologic oncology: a systematic review of the literature. Gynecol Oncol. 2016;143(2):439–42.

    Article  PubMed  Google Scholar 

  37. Mikaela S, Katz AG, Valente A, Richardson D, Holman LL. Implementation of a standard same day discharge protocol for minimally invasive hysterectomies in the division of gynecologic oncology: a quality improvement project. Gynecol Oncol Rep. 2022;44:S21–2.

    Article  Google Scholar 

  38. Brackmann M, Carballo E, Uppal S, Torski J, Reynolds RK, McLean K. Implementation of a standardized voiding management protocol to reduce unnecessary re-catheterization—a quality improvement project. Gynecol Oncol. 2020;157(2):487–93.

    Article  PubMed  Google Scholar 

  39. Propst K, Tunitsky-Bitton E, O’Sullivan DM, Steinberg AC, LaSala C. Phenazopyridine for evaluation of ureteral patency: a randomized controlled trial. Obstet Gynecol Surv. 2016;71(11):656–8.

    Article  Google Scholar 

  40. Bakkum-Gamez JN, Langstraat CL, Martin JR, Lemens MA, Weaver AL, Allensworth S, Dowdy SC, Cliby WA, Gostout BS, Podratz KC. Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma. Gynecol Oncol. 2012;125(3):614–20.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Gungorduk K, Ozdemir IA, Gungorduk O, Gulseren V, Gokcu M, Sanci M. Effects of coffee consumption on gut recovery after surgery of gynecological cancer patients: a randomized controlled trial. Am J Obstet Gynecol. 2017;216(2):145.e141–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecologic Oncology, H Lee Moffitt Cancer Center, Tampa, FL, USA

    Monica Avila

  2. Department of Anesthesia, H Lee Moffitt Cancer Center, Tampa, FL, USA

    Rohini Kotha

Authors
  1. Monica Avila
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rohini Kotha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monica Avila .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, Moffitt Cancer Center, Tampa, FL, USA

    Jeffrey Huang

  2. Department of Anesthesiology, University of Louisville Hospital, Louisville, KY, USA

    Jiapeng Huang

  3. Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA, USA

    Henry Liu

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Avila, M., Kotha, R. (2023). Uterine Cancer Surgery. In: Huang, J., Huang, J., Liu, H. (eds) Anesthesia for Oncological Surgery. Springer, Cham. https://doi.org/10.1007/978-3-031-50977-3_55

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-50977-3_55

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-50976-6

  • Online ISBN: 978-3-031-50977-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation